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Abstract
Background: Conventional right atrial appendage pacing (RAAp) eliminates the electro-
physiological consequences of bradycardia only, leading to suppression of the rhythm-dependent
arrhythmias but in some patients RAAp may increase AF recurrences or even promote it in
patients without AF history. Relatively rare incidence of AF in patients implanted with single
lead VDD pacing system may indicate RAAp influence. Atrial conduction disturbances (ACD)
are the known substrate of re-entrant atrial arrhythmias and their detection is important for the
selection of proper therapy. Time-domain analysis of P-wave in signal-averaged ECG (SA-ECG)
recorded from chest leads is an accepted method evaluating inhomogeneity of atrial excitation,
predictive for atrial arrhythmias. The aim of our study was to estimate the effect of RAAp on
SA-ECG recorded from conventional external and from intraatrial leads.
Methods: Recordings were performed in 24 patients during biatrial pacing system implantation.
A surface SA-ECG was obtained from orthogonal leads and intraatrial signals were recorded and
averaged separately from the right and left atrium at SR and RAAp (LA pacing was temporary
switched). We analyzed standard SA-ECG parameters (P/A wave duration, RMS20 and LAS5)
and the presence of atrial late potentials (ALP-Pdur > 125 ms and RMS20 < 2.40 mV).
Results and conclusions: RAAp significantly prolongs all parameters reflecting atrial activa-
tion (P ECG, TAAT, SA-ECG Pdur, SA-IEGM Adur in RA and LA) by 20 to 30 ms in
comparison to SR. RAAp decreases RMS20 and prolongs LAS5 values both in external and
intraatrial leads, which reflects increased micro-oscillations in the final portion of atrial poten-
tial. The lower RMS20 and higher LAS5 values in RA compared to LA suggest less homogenous
depolarization in right atrium. This may suggest that atrial activation extinguishes more
homogenously in LA. A different explanation may be that the observed sluggish ending of RA
signal may be the result of a far-field sensing from the LA. The strong correlations between RAA
paced P wave, TAAT, SA-ECG Pdur, SA-IEGM RA and LA Adur confirm that those param-
eters reproduce mostly the velocity of conduction within the atria. Our findings indicates signifi-
cant aggravation of ACD (mainly in RAA) and suggests that the search is needed for another RA
lead location for permanent single site and biatrial pacing. (Cardiol J 2007; 14: 372–383)
Key words: signal-averaged ECG, biatrial pacing, intra-atrial signal, atrial late
potentials, atrial fibrillation
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Introduction
Cardiac pacing has become a widely accepted
non-pharmacological approach to atrial arrhythmias,
as the value of antiarrhythmic drugs is limited and
knowledge on the mechanisms of arrhythmia has
broadened [1–4]. The distortions of atrial repolari-
sation (its shortening, inadequate adaptation to the
heart rate and increased dispersion) are the main
substrate of the arrhythmias, while atrial premature
beats and abrupt changes in heart rate (short-long-
-short cycle) [4–6] are the recognised triggers. The
main favourable effects of atrial pacing are: 1) the rate
of the control-stable cycle length decreases the dis-
persion of repolarisation, leading to the suppression
of rhythm-dependent arrhythmias such as vagally-
mediated atrial fibrillation (AF) or bradycardia-
-dependent AF, by reduction of “escape” atrial ectopic
activity [2–4, 7]; 2) the overdrive suppression of atrial
ectopy (the shortening of paced cycle length after an
atrial ectopic beat; 3) the elimination of compensa-
tory pauses; the arrhythmogenic effect of altering
cycle length (long-short or short-long-short) has
been demonstrated in ventricular arrhythmias, and
its role in the initiation of atrial arrhythmias is un-
der consideration [8, 9].
The “classic” right atrial appendage pacing
(RAAp) with fixed rhythm eliminates the electro-
physiological consequences of bradycardia only,
thus having a satisfactory effect in vagally-mediat-
ed AF [10] but a less satisfactory one in the brady-
tachycardia syndrome [1–4, 7–9]. To enhance its
antiarrhythmic efficacy consistent atrial pacing al-
gorithms have been introduced [8, 9]. In some pa-
tients right atrial pacing may increase instances of
the recurrence of AF or even promote AF in pa-
tients without a history of it [1, 11–13]. This phe-
nomenon has more frequently been observed after
the implantation of an active-fixation lead to the free
wall of the right atrium (RA). The relatively rare
incidence of AF in patients implanted with a single-
lead VDD pacing system has been explained by the
absence of the “irritating” influence of the atrial lead
[12, 14]. Since the unfavourable electrophysiologi-
cal effects of RA pacing and the role of interatrial
conduction disturbances have become better known
[18, 19], resynchronising atrial pacing has been
widely applied [1–3, 7, 11, 20].
Our previous studies on the electrophysiolog-
ical effects of RAAp based on analysis of IEGM trac-
ings obtained via pacemaker telemetry, revealed
that this pacing mode caused prolongation of AV
activation (+30 ms), P wave duration (+17 ms), in-
teratrial conduction time (+40 ms) and total atrial
conduction time (TAAT) by 25 ms, in comparison
to sinus rhythm. The changes were inversely pro-
portional to the pacing cycle length. Despite the in-
crease in data on the unfavourable proarrhythmic
effects of RAAp [21–23] and the unequivocal opin-
ion of electrophysiologists, the RAA is still the most
frequent pacing site in the RA, even in patients with
brady-tachycardia syndrome.
In patients with recurrent drug-resistant atri-
al arrhythmias, in whom inter- and intra-atrial con-
duction disturbances can be detected, the presence
of micropotentials at the final phase of atrial activa-
tion should be anticipated [24]. Conduction distor-
tions within the atria resulting from RAAp can oc-
cur on a “macro” scale and be assessed by P wave
duration and TAAT [21–23] or on a “micro” scale,
reflected by the root mean square voltage of the last
20 ms of atrial activation (RMS20) and the duration
of the low-amplitude signal < 5 mV (LAS5) [24–27].
The literature indicates that RAAp should increase
conduction disturbances [15–17] and the inhomo-
geneity of depolarisation, which may be reflected
by abnormal RMS20 and LAS5 values, resulting in
positive atrial late potentials (ALP) criteria [28, 29].
The aim of the study was to estimate the elec-
trophysiological effects of conventional RAAp upon
conduction disturbances within the atria and the
homogeneity of atrial depolarisation, assessed by
the values of RMS20 and LAS5, as well as the pres-
ence of ALP criteria. Moreover, we intended to
assess the influence of RAAp upon the homogene-
ity of activation measured separately in the left atri-
um (LA) and RA, since there are no published stud-
ies concerning this problem.
Methods
Patients
The study was conducted on a group of 24 pa-
tients (15 female, 9 male, with a mean age of 68.8
± 9.97 years) eligible for permanent biatrial pac-
ing. In 7 patients (29.2%) sporadic AF, in 8 patients
(33.3%) recurrent AF and in 9 patients (37.5%) fre-
quent AF (according to the Kingma and Suttorp
paradigm [30]) was identified. Owing to the con-
siderable arrhythmia burden the ongoing medica-
tion was not modified; discontinuation of treatment
could provoke AF episodes, thus impeding the
measurement of pacing and sensing conditions.
During the pacemaker implantation procedures
5 patients were treated with one drug (amiodarone
or propafenone), 8 were on two drugs (propafenone
and sotalol/amiodarone) and 11 patients (46%) had
no ongoing antiarrhythmic medication.
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Procedures
The following measurements were taken dur-
ing sinus rhythm and RAAp: 1) 12-lead ECG with
100 mm/s speed 80 mm/1 mV gain; 2) IEGM record-
ing from RAA and coronary sinus (CS), simultane-
ously with ECG lead II; 3) SA-ECG recording from
external orthogonal leads; 4) SA-IEGM recording
from the RA and LA separately. Intra-atrial signals
were obtained with standard bipolar pacing leads
introduced during the pacemaker implantation pro-
cedure and subsequently employed for permanent
pacing.
External SA-ECG recording and processing
Equipment constructed in the National Insti-
tute of Cardiology (Warsaw) was employed for sig-
nal recording and processing. It consisted of a micro-
potentials amplifier (noise < 1.5 µV in 0.1–300 Hz
bandwidth, CMRR > 130 Db), 12-bit A/D convert-
er, 486 CPU PC and software designed for signal-
averaging processing and subsequent analysis of
data. Standard Ag/AgCl electrodes were applied on
cleansed chest skin. The P wave was derived from
three bipolar orthogonal (Frank) leads. Signals, from
each lead, were amplified (1000¥), passed through
a band-pass filter (cut-off frequency 0.1–300 Hz) and
digitised by the A/D converter with a 12-beat accu-
racy. The signal-averaging process was triggered
by the R wave during sinus rhythm and the pacing
spike during RAAp. Ectopic beats, if present, were
identified and rejected. Approximately 50 beats
were averaged and stored on the PC HD. The proc-
ess has been described previously [11].
High-gain SA-ECG P wave parameters
time-domain analysis
The first stage was to combine filtered (But-
terworth bidirectional filter) and averaged signals
from three leads, X, Y and Z, to a spatial vector
magnitude (X2 = Y2 + Z2)1/2. The onset and offset of
the P wave were defined as the point at which the
atrial signal exceeded and returned to the 1.5 µV
level respectively. The following parameters were
measured and calculated automatically: 1) filtered
P wave duration (Pdur); 2) root mean square volt-
age of the final 20 ms of filtered P wave (RMS20);
3) duration of low-amplitude signal < 5 µV (LAS5).
The ALP were considered positive with Pdur > 125 ms
and RMS20 < 2.4 µV [11].
Intracardiac SA-IEGM recording and
processing
Three bipolar pacing leads were used: a stand-
ard J-shaped lead implanted into the RAA, a second
lead introduced into the CS and a third lead (for
permanent ventricular pacing), which was tempo-
rarily placed in the LRA position. The equipment
described above was employed for signal recording
and processing. To obtain RA and LA signals, int-
racardiac leads were attached to the micropotentials
amplifier via sterile connectors, according to the
scheme in Figure 1. The right atrial electrogram
was recorded from three combined intra-atrial leads
X’ Y’ Z’ and the left atrial electrogram from the
X’’ Y’’ Z’’ leads. The signal from each lead was aug-
mented and filtered in the same mode as during
external signal recording. The averaging process
was triggered by the A wave during sinus rhythm
and the pacing spike during RAAp, and the param-
eters obtained were analysed in the same way as
the external SA-ECG. The technique employed has
been described previously [30–32].
Interatrial conduction evaluation with
internal electrogram recordings
The internal electrogram (IEGM) was record-
ed from the RAA and CS leads connected to a dual-
chamber pacemaker via telemetry (Fig. 2) simulta-
neously with lead II ECG. The following timing
parameters were determined: 1) P wave duration
in leads II or III at high resolution ECG; 2) intera-
trial conduction time (IACT) measured from the
onset of the A wave in the RAA signal to the onset
of the A wave in the CS signal; 3) total atrial activa-
tion time (TAAT) measured from the onset of the
P wave in the lead II ECG to the end of atrial acti-
vation in the CS signal.
Statistical analysis
Significance of difference of the means in all
subgroups was assessed using variance F test and
between-group significance of difference of the
means was tested using lowest significant difference
(LSD) test. For significance of difference of the
Figure 1. The scheme presents the connections of in-
tracardiac leads to obtain right atrial (X’ Y’ Z’) (A) and
left atrial (X’’ Y’’ Z’’) (B) signals.
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means between two subgroups t-test for unpaired
data was used. Correlation between parametric val-
ues was assessed by Pearson correlation coefficient.
The study was approved by the Bioethical
Committee of Medical University of Lublin (approval
KE-0254/70/2003).
Results
The results are presented in Table 1. The aver-
age P wave duration was 158 ms at sinus rhythm and
increased to 181 ms at RAAp. A significant influence
was exerted by RAA on atrial activation, assessed by
the interatrial conduction time (104 vs. 120 ms), TAAT
(182 vs. 201 ms), SA-ECG P wave duration (156 vs.
199 ms) and SA-IEGM A wave duration from the RA
(175 vs. 201 ms) and LA (175 vs. 201 ms). There was
also a significant influence upon the duration of low-
amplitude potential (LAS5), which was markedly
prolonged in external SA-ECG (6.7 vs. 14.5 ms) and
intra-atrial SA-IEGM in the RA (12.9 vs. 24.6 ms)
and the LA (9.1 vs. 13.5 ms) during RAAp. There
was no clear influence of this pacing mode upon the
RMS20 values. Table 2 illustrates the statistical eval-
uation of the above data (Fig. 3).
The results imply that RAAp not only signifi-
cantly prolongs atrial activation, but also increas-
es the inhomogeneity of the final part of atrial po-
tential, worsening the asynchrony of atrial activa-
tion. This is consistent with clinical observations.
The conduction of atrial activation and the ho-
mogeneity of its last part can be illustrated by three
basic SA-ECG parameters: the P wave duration
(Pdur), the root mean square voltage of the final
20 ms of the P wave (RMS20) and the duration of
the low-amplitude signal < 5 µV (LAS5). The ho-
mogenous atrial activation is characterised by
a short Pdur and LAS5, with a high RMS20 [24–29].
The coincident abnormal values of Pdur and RMS20
lead to the detection of the ALP, a widely accepted
predictor of atrial arrhythmias. Table 3 presents the
rate of ALP criteria occurrence in the external and
intra-atrial leads at SR and RAAp.
Atrial late potentials criteria were present in 79%
of patients in external SA-ECG and in 96% and 86%
of patients in RA and LA SA-IEGM respectively.
RAAp yielded positive ALP criteria in all but one
(in RA SA-IEGM) patients, which additionally con-
Figure 2. The internal electrogram (IEGM) was recor-
ded from the right atrial appendage (RAA) and corona-
ry sinus (CS) leads connected to a dual-chamber pace-
maker via telemetry.
Table 1. Comparison of interatrial conduction parameters and high-gain SA P&A wave time domain
during sinus rhythm and right atrium appendage pacing.
Rhythm Sinus rhythm Right atrium appendage pacing
parameters N Aver. Med. Min. Max. SD N Aver. Med. Min. Max. SD
Pdur ECG 24 157.7 159.0 125.0 199.0 16.0 24 180.9 180.0 140.0 245.0 26.8
IACT 24 103.7 99.5 55.0 148.0 22.6 24 119.9 123.5 51.0 165.0 24.8
TAAT 24 181.5 182.0 144.0 225.0 22.4 24 201.1 199.0 160.0 265.0 28.9
Ext. SA Pdur 24 156.2 155.4 119.3 186.8 16.8 24 188.9 185.1 150.7 253.8 30.5
Ext. SA RMS20 20 2.17 1.96 1.09 3.69 0.76 24 1.82 1.78 0.68 3.14 0.71
Ext. SA LAS5 24 6.68 5.50 0.00 26.7 7.48 24 14.59 13.35 1.60 64.40 12.81
Int. SA RA Adur 24 174.8 168.8 144.4 224.5 24.1 24 199.1 187.1 158.0 256.9 29.1
Int. SA RA RMS20 23 1.77 1.69 0.75 3.46 0.72 22 1.35 1.12 0.64 3.35 0.64
Int. SA RA LAS5 23 12.91 11.00 0.00 33.00 7.92 22 24.62 18.80 3.10 84.80 19.99
Int. SA LA Adur 23 175.3 169.6 138.2 237.1 26.7 24 201.3 189.1 151.7 270.0 31.2
Int. SA LA RMS20 15 2.33 1.78 0.98 4.81 1.19 16 1.96 1.93 0.84 3.64 0.84
Int. SA LA LAS5 15 9.01 9.40 0.00 18.80 6.17 16 13.45 9.45 0.00 61.20 14.10
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firms the potential proarrhythmic effect of this pac-
ing mode.
Subsequently the differences between the pa-
rameters obtained from the external and (separate-
ly) intra-atrial leads were analysed (Table 4). It
could be anticipated that the higher amplitude of the
intra-atrial signals would give the opportunity to as-
sess more extensive trial activation (omitted in the
external leads).
The RAA paced SA atrial potential recorded
from the intra-atrial leads was significantly longer
(approx. 10 ms) than the external SA P wave re-
corded from Frank’s leads. There was no substan-
tial difference between SA-IEGM A wave duration
recorded from the RA and the LA, although it must
be recognised that different timings were meas-
ured; the onset and the ending of the LA A wave
was recorded noticeably later than the RA A wave
timing. The LAS5 values were significantly longer
in the RA than in the LA and external leads. There
were no significant differences between RMS20
values recorded from external and RA leads; in con-
trast, the RMS20 value was significantly higher in
the LA than in the RA. This may suggest that atrial
activation extinguishes more homogenously in the
LA. A different explanation may be that the slug-
gish ending of the RA signal observed may be the
result of far-field sensing from the LA (Fig. 4).
The correlations between RAA paced ECG
P wave duration, IACT, TAAT and the SA-ECG/
/IEGM parameters analysed are presented in Ta-
bles 5, 6 and 7. The results indicate that RAA paced
P wave duration assessed in external ECG does not
reflect the whole atrial activation, since it is notice-
ably shorter than TAAT, which implies that a con-
siderable portion of atrial potential is omitted in
external ECG. Although the SA-IEGM Adur values
were virtually equal in the Ra and LA, it is essen-
tial that the onset of the A wave was apparently
recorded later in the LA than in the RA SA-IEGM,
which indicates that in both electrograms the acti-
vation of different atrial regions was evaluated.
Discussion
A biatrial pacing system gives the opportunity
of simultaneous, non-invasive registration of signals
from the RA and LA. We implemented this technique
in our previous studies [28, 29], demonstrating an
unfavourable prolongation of atrial potential by
Table 2. Interatrial conduction and high-gain SA P&A wave parameters during SR and RAAp.
Comparison and statistical evaluation differences of average values.
Parameters Rhythm N Average SD p
P duration SR
24
157.67 15.99
0.000
High-resolution ECG RAAp 180.92 26.82
TAAT SR
24
181.50 22.46
0.000
(IEGM) RAAp 201.12 28.96
SA P duration SR
24
156.19 16.84
0.000
Ext. leads RAAp 188.91 30.49
RMS20 SR
20
2.17 0.76
0.177
Ext. leads RAAp 1.85 0.71
LAS5 SR
24
6.68 7.48
0.001
Ext. leads RAAp 14.59 12.81
SA A duration SR
24
174.77 24.10
0.000
Int. RA leads RAAp 199.13 29.10
RMS20 SR
16
1.48 0.44
0.400
Int. RA leads RAAp 1.22 0.47
LAS5 SR
16
15.42 27.58
0.003
Int. RA leads RAAp 27.58 21.08
SA A duration SR
23
175.29 26.66
0.000
Int. LA leads RAAp 200.26 31.51
RMS20 SR
12
2.09 0.93
0.179
Int. LA leads RAAp 1.65 0.60
LAS5 SR
12
9.82 5.60
0.135
Int. LA leads RAAp 15.18 15.95
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Table 3. Presence of atrial late potentials (ALP) criteria during sinus rhythm and right atrium append-
age (RAA) pacing in conventional and intra-atrial SA ECG/IEGM.
Rhythm Leads Ext. Int. RA Int. LA
Sinus rhythm ALP — YES 19/24 (79.2%) 23/24 (95.8%) 19/22 (86.4%)
ALP — NO 5/24 (20.8) 1/24 (4.2%) 3/22 (14.6%)
Lack* 0/24 (0%) 0/24 (0%) 2/24 (8.3%)
RAA pacing ALP — YES 24/24 (100.0%) 22/23 (95.6%) 24/24 (100.0%)
ALP — NO 0/24 (0%) 1/23 (4.3%) 0/24 (0%)
Lack* 0/24 (0%) 1/24 (4.2%) 0/24 (0%)
*Impossible to evaluate (terminal part of A wave cancelled in V wave)
Figure 3. Right atrial appendage (RAA) pacing prolongs total atrial activation time (TAAT) and P-Q/S-Q interval.
RAAp; this is consistent with the data obtained by
invasive methods by other authors [15–18].
Analysis of the time- and frequency-domain
parameters of the signal-averaged P wave detects
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Table 4. Comparison of right atrium appendage paced atrial potential duration and its RMS20 and
LAS5 in recordings obtained from external (Frank’s) and intra-atrial leads.
Examined N Leads Ave- SE Analysis NIR test
parameters rage of variance Groups Compa- Aver. SD p
rison diff. of diff.
SA ECG/IEGM 24 Extern. 188.9 6.22
F = 1054.2
1 1 vs. 2 –10.2 2.20 0.000
P&A wave 24 Int. RA 199.1 5.94
P = 0.000
2 1 vs. 3 –12.4 2.20 0.000
duration 24 Int. LA 201.3 6.37 3 2 vs. 3 –2.18 2.20 0.333
SA ECG/IEGM 16 Extern. 1.59 0.13
F = 201.7
1 1 vs. 2 0.32 0.19 0.096
P&A RMS20 16 Int. RA 1.17 0.10
P = 0.000
2 1 vs. 3 –0.47 0.19 0.016
16 Int. LA 1.96 0.21 3 2 vs. 3 –0.79 0.19 0.000
SA ECG/IEGM 16 Extern. 18.75 3.41
F = 62.2
1 1 vs. 2 –9.32 5.62 0.107
P&A LAS5 16 Int. RA 28.07 5.19
P = 0.000
2 1 vs. 3 5.30 5.62 0.353
16 Int. LA 13.45 3.52 3 2 vs. 3 14.62 5.62 0.014
Figure 4. Signal-averaged electrogram obtained from external and intra-atrial leads in the same patient during sinus
rhythm and right atrial appendage (RAA) pacing reveals its unfavourable effect on atrial activation synchrony.
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Table 6. Examination of mutual correlation (r Pearson’s) between interatrial conduction time (IACT)
values and SA atrial potential duration, its RMS20 and LAS5 examined in external and intra-atrial
recordings during RAA pacing.
Parameters N Average SD r (X, Y) t p
IACT (IEGM)
24
119.9 24.8
0.65 3.99 0.000
Ext. SA ECG Pdur 188.9 30.5
IACT (IEGM)
24
119.9 24.8
–0.07 0.336 0.739
Ext. SA ECG RMS20 1.82 0.71
IACT (IEGM)
24
119.9 24.8
0.32 1.570 0.130
Ext. SA IECG LAS5 14.59 12.81
IACT (IEGM)
24
119.9 24.8
0.69 4.480 0.000
Int. SA IEGM RA Adur 199.1 29.1
IACT (IEGM)
22
119.8 25.8
–0.16 0.726 0.476
Int. SA IEGM RA RMS20 1.35 0.64
IACT (IEGM)
22
119.7 25.8
0.27 1.243 0.227
Int. SA IEGM RA LAS5 24.62 19.99
IACT (IEGM)
24
119.9 24.8
0.69 4.510 0.000
Int. SA IEGM LA Adur 201.3 31.2
IACT (IEGM)
16
123.4 22.3
–0.19 0.727 0.478
Int. SA IEGM LA RMS20 1.96 0.84
IACT (IEGM)
16
123.4 22.3
0.25 0.965 0.350
Int. SA IEGM LA LAS5 13.45 14.10
Table 5. Examinations of mutual correlation (r Pearson’s) between RAA paced P wave duration (ECG)
and SA atrial potential duration, its RMS20 and LAS5 examined in external and intra-atrial recordings.
Parameters N Average SD r (X,Y) t p
High res. ECG Pdur
24
180.9 26.8
0.91 10.170 0.000Ext. SA ECG Pdur 188.9 30.4
High res. ECG Pdur
24
180.9 26.8
0.02 0.097 0.923Ext. SA ECG RMS20 1.82 0.71
High res. ECG Pdur
24
180.9 26.8
0.24 1.171 0.254Ext. SA ECG LAS5 14.59 12.81
High res. ECG Pdur
24
180.9 26.8
0.90 9.481 0.000Int. SA IEGM RA Adur 199.1 29.1
High res. ECG Pdur
22
181.0 28.1
–0.32 –1.495 0.150Int. SA IEGM RA RMS20 1.35 0.64
High res. ECG Pdur
22
181.0 28.1
0.60 3.351 0.003Int. SA IEGM RA LAS5 24.62 19.99
High res. ECG Pdur
24
180.9 26.8
0.86 7.795 0.000Int. SA IEGM LA Adur 201.3 31.2
High res. ECG Pdur
16
184.6 30.4
0.20 0.75206 0.464Int. SA IEGM LA RMS20 1.96 0.84
High res. ECG Pdur
16
184.6 30.4
0.06 0.227 0.823Int. SA IEGM LA LAS5 13.45 14.10
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the decreased homogeneity of atrial depolarisation
and helps to predict the risk of recurrent atrial ar-
rhythmias [24–27]. In previous papers we described
the prolongation of signal-averaged P wave dura-
tion by RAAp [28, 29].
The delayed activation of the LA (particularly
in patients with interatrial conduction disturban-
ces) is generally recognised. Thus the final part
of the SA-ECG P wave reflects the LA potential
and the RMS20 and LAS5 parameters reveal mi-
cro-oscillations originating in the LA. On the oth-
er hand, the key role of RA conduction disturbanc-
es in the maintenance of atrial arrhythmias is
known [13–16, 20].
The techniques described were not capable of
evaluating the late potentials in the RA alone and sub-
sequently of judging the effect of RAAp upon RA mi-
cro-oscillations. These questions lead us to a hypoth-
esis that the potentials recorded from three intra-atrial
leads, processed with a standard signal-averaging
technique, will possibly be a valuable instrument for
the evaluation of the electrophysiological effects of
atrial pacing. The results demonstrated that RAAp
prolongs all parameters reflecting atrial activation
(P ECG, TAAT, SA-ECG Pdur, SA-IEGM RA and
LA Adur) by 20 to 30 ms. Additionally, RAAp signif-
icantly prolonged LAS5 in the external and RA leads,
and to some extent (but not significantly) decreased
the RMS20 values in all leads. Both changes in
RMS20 and LAS5 values reflect increased micro-os-
cillations in the final portion of the atrial potential at
RAAp. The lower RMS20 and higher LAS5 values in
the RA compared to the LA suggest less homoge-
nous depolarisation in the RA. The strong correlations
between the RAA paced P wave, TAAT, SA-ECG Pdur,
SA-IEGM RA and LA Adur confirm that these param-
eters mostly reproduce the velocity of conduction with-
in the atria. The lack of correlation between ECG
P wave duration, TAAT or IACT and the values of the
RMS20 and LAS5 parameters indicates that the in-
teratrial conduction disturbances are not clearly re-
lated to the presence and duration of micro-oscilla-
tions in the final part of RAA paced atrial potential.
There are a few published papers concerning
the application of time- or frequency-domain analy-
sis of SA-ECG parameters for the evaluation of dif-
ferent atrial pacing modes [33–35]. Gribbin et al. [33]
compared the effects of long-term physiological
(AAI, DDD) and non-physiological (VVI) pacing on
the time- and frequency-domain SA-ECG parame-
ters at sinus rhythm (30/min pacing rate) in patients
with sick sinus syndrome. Although there was no
Table 7. Examination of mutual correlation (r Pearson’s) between total atrial activation time (TAAT)
values and SA atrial potential duration, its RMS20 and LAS5 examined in external and intra-atrial
recordings during RAA pacing.
Parameters N Average SD r (X, Y) t p
TAAT (IEGM)
24
201.1 28.9
0.87 8.491 0.000
Ext. SA ECG Pdur 188.9 30.5
TAAT (IEGM)
24
201.1 28.9
–0.15 0.722 0.477
Ext. SA ECG RMS20 1.82 0.71
TAAT (IEGM)
24
201.1 28.9
0.48 2.538 0.018
Ext. SA ECG LAS5 14.59 12.81
TAAT (IEGM)
24
201.1 28.9
0.90 9.916 0.000
Int. SA IEGM RA Adur 199.1 29.1
TAAT (IEGM)
22
201.2 30.2
–0.45 2.230 0.037
Int. SA IEGM RA RMS20 1.35 0.64
TAAT (IEGM)
22
201.2 30.2
0.42 2.075 0.0515
Int. SA IEGM RA LAS5 24.62 19.99
TAAT (IEGM)
24
201.1 28.9
0.91 10.444 0.000
Int. SA IEGM LA Adur 201.3 31.2
TAAT (IEGM)
16
206.0 30.9
–0.08 0.295 0.772
Int. SA IEGM LA RMS20 1.96 0.84
TAAT (IEGM)
16
206.0 30.9
0.34 1.376 0.190
Int. SA IEGM LA LAS5 13.45 14.10
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significant change in LA dimensions, there was
a significant prolongation of the signal-averaged
P wave duration in the group with non-physiological
pacing. This unfavourable electrophysiological re-
modelling may explain the higher incidence of atrial
arrhythmias in patients with VVI pacing. Keane et
al. [34] analysed signal-averaged P wave time- and
frequency-domain parameters in sick sinus syn-
drome patients with and without paroxysmal AF,
both at sinus rhythm and RAAp. The SA P wave
duration at sinus rhythm was shortest in the control
group (134 ms), longer in the SSS group (140 ms)
and significantly prolonged in the group with PAF
(156 ms); there were no significant differences in the
RMS20 values. RAAp additionally prolonged SA P
wave duration in patients with SSS (140 vs. 167 ms)
and PAF (156 vs. 170 ms). The authors concluded
that RAAp discloses conduction disorders within the
atria and can thus be a useful instrument for the se-
lection of the optimal pacing mode [34].
Yamada et al. [35] in 2001 published the results
of RAA and Bachmann’s bundle (BB) pacing, assessed
with the use of SA-ECG time-domain parameters. In
the study referred to BB pacing reduced (compared
to SR) SA P wave duration (126 vs. 122 ms) and in-
creased RMS20 (2.9 vs. 2.0 µV). The RAAp resulted
in the opposite effects. The authors considered ALP
criteria as P > 132 ms and RMS20 < 2.5 µV. They
found ALP positive in 80% of patients in the sub-
group with PAF and in 20% of the subgroup without
arrhythmias. BB pacing changed the ratio to 10% and
13%, and RAAp to 70% and 27% respectively. In the
discussion the authors emphasise the arrhyth-
mogenic effect of RAAp [4, 35].
The data presented lends support to the choice
of an alternative atrial pacing site in patients with
interatrial conduction disturbances and recurrent
atrial arrhythmias.
Limitations of the study
The signal-averaging process was triggered by
the R wave, since P wave synchronisation was in-
adequate in patients with a fragmented low-ampli-
tude P wave, which was frequent in the group stud-
ied. The “left atrial” lead system applied is not pure-
ly left atrial; the introduction of a multipolar
catheter to the LA via the trans-septal approach and
selection of three bipolar leads would be a better
option. It is a routine procedure in pulmonary vein
ectopy mapping and ablation, but not during pace-
maker implantation. In the study group there were
no indications for left heart catheterisation, and
therefore we applied a pacing electrode, introduced
to the CS, connected to the tip and ring of the elec-
trode placed in the low RA. Consequently, in the
“left atrial” leads the activation of the lower part of
the RA was additionally recorded. Since the final
part of the LA excitation has superior importance,
we consider this solution satisfactory.
At the beginning of the study there was some
doubt as to whether the fragmented termination of
the potential recorded from the RA truly reflected
RA activation or just far-field sensing from the LA.
Parallel recordings performed during LA and bia-
trial pacing, however, confirmed the existence of
clearly RA late potentials, since the LA was acti-
vated earlier during pacing [36, 37]. The study was
performed in the selected group of patients with
recurrent atrial arrhythmia and considerable con-
duction disturbances within the atria, and thus our
conclusions must not be applied to the general pop-
ulation of patients with paroxysmal atrial fibrillation.
Conclusions
1. RAA pacing significantly prolongs all parame-
ters reflecting atrial activation (P ECG, TAAT,
SA-ECG Pdur, SA-IEGM Adur in RA and LA)
by 20 to 30 ms.
2. RAA pacing decreases RMS20 and prolongs
LAS5 values both in external and intra-atrial
leads, which reflects increased micro-oscilla-
tions in the final portion of atrial potential.
3. The lower RMS20 and higher LAS5 values in
the RA than in the LA suggest less homoge-
nous depolarisation in the RA. This may sug-
gest that atrial activation extinguishes more
homogenously in the LA. A different explana-
tion may be that the sluggish ending of the RA
signal observed may be the result of far-field
sensing from the LA.
4. The strong correlations between the RAA
paced P wave, TAAT, SA-ECG Pdur, SA-IEGM
RA and LA Adur confirm that these parame-
ters mostly reproduce the velocity of conduc-
tion within the atria.
5. The lack of correlation between ECG P wave
duration, TAAT or IACT and the values of the
RMS20 and LAS5 parameters indicates that in-
teratrial conduction disturbances are not clear-
ly related to the presence and duration of mi-
cro-oscillations in the final part of RAA paced
atrial potential.
6. The data presented encourage the search for
an alternative atrial pacing site in patients with
interatrial conduction disturbances and recur-
rent atrial arrhythmias.
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